
    
      Non-randomized feasibility study with paclitaxel, carboplatin, bintrafusp alfa, and
      radiation. Paclitaxel 50 mg/m2 and carboplatin AUC = 2 will be given intravenously (i.v.) on
      days 1, 8, 15, 22, 29 and 36. Bintrafusp alfa will be given i.v. every three weeks on day 1,
      22, and 43 at a dose of 2400 mg. External beam radiotherapy will be delivered to a total dose
      of 50.4 Gy in 28 fractions of 1.8 Gy, 5 fractions per week, starting the first day of the
      first cycle of chemotherapy.
    
  